Global: Early-stage funding focuses on diagnostics

Early-stage funding last week was dominated by diagnostics companies, especially those in Asia. Hangzhou-based diagnostics company Broncus Holding Company has closed its Series C funding to develop markets and technology across lung cancer, emphysema and other important lung diseases. The round was led by Lake Bleu Capital and included Baidu Capital, the venture arm of…

You must be a HMI Subscriber to view this content.

Subscribe Now »